-
TMEM16F, Ferroptosis, and Tumor Immune Rejection
2026-09-19
Yang et al. identify TMEM16F-mediated plasma-membrane lipid scrambling as a late-stage suppressor of ferroptosis, showing that phospholipid redistribution can limit membrane collapse after lipid peroxide accumulation. Disrupting this response increases tumor vulnerability and strengthens PD-1 blockade, linking membrane biophysics with antitumor immunity.
-
Agatoxin-IVA Channels in Cardiac Vagal Neurons
2026-09-18
Wang, Irnaten, and Mendelowitz used whole-cell patch-clamp recordings to show that agatoxin-IVA-sensitive voltage-dependent calcium channels contribute to both presynaptic and postsynaptic nicotinic activation of cardiac vagal neurons. Their antagonist comparison separated this pathway from N- and Q-type channels and suggested an additional, selective role for L-type channels in glutamatergic synaptic facilitation.
-
Isorhamnetin: From Oocyte Signal to Assay Design
2026-09-18
Isorhamnetin is a flavonoid research compound that connects PI3K/Akt activation with oxidative-stress control, apoptosis, and oocyte maturation. This article moves beyond a standard workflow to explain how its chemistry, controls, and layered readouts support stronger causal assay design.
-
Atorvastatin in Ferroptosis Research
2026-09-17
Atorvastatin extends beyond cholesterol metabolism research into ferroptosis-oriented hepatocellular carcinoma workflows, while retaining value in vascular and cardiovascular models. This practical guide connects product handling, dose-finding, migration assays, redox readouts, and biomarker-guided experimental design.
-
NAT1–ENO1–Lactate Axis in Colorectal Cancer
2026-09-17
A 2026 MedComm study defines NAT1 as a metabolic–immune regulator in colorectal cancer, linking ENO1 acetylation and lactate production to TRAF6-dependent PD-L1 stabilization. Its integrated database, multi-omics, mechanistic, and mouse-model analyses suggest that disrupting this axis may improve checkpoint immunotherapy, while pharmacological LDHA inhibition remains a hypothesis-generating extension rather than a tested intervention in the paper.
-
Bazedoxifene Workflow for ER and Bone Research
2026-09-16
Bazedoxifene combines nanomolar estrogen-receptor engagement with tissue-selective activity, making it useful for linking receptor pharmacology to bone-model endpoints. This practical guide covers formulation, ER assays, ovariectomized-rat study design, comparator logic, and troubleshooting for osteoporosis treatment research.
-
P-Type Calcium Channels in Cardiac Vagal Neurons
2026-09-15
Wang, Irnaten, and Mendelowitz used whole-cell patch clamp recordings to show that agatoxin-IVA-sensitive calcium channels contribute to both presynaptic and postsynaptic nicotinic activation of cardiac vagal neurons. The study distinguishes P-type channel involvement from effects mediated by L-, N-, and Q-type channels, providing a mechanistic framework for analyzing cholinergic control of cardiac autonomic circuits.
-
Laminin (925-933) for Adhesion Assays
2026-09-15
Laminin (925-933) is a defined Laminin B1 chain peptide for separating receptor-driven adhesion and chemotaxis from the variability of full-length matrix proteins. Its concentration-controlled format supports reproducible cell migration studies, competitive ligand experiments, and mechanistic basement membrane protein research.
-
DiscoveryProbe FDA-approved Drug Library for CRISPR
2026-09-14
Use clinically established compounds to map DNA-repair pathway choice, prioritize repurposing candidates, and connect CRISPR editing outcomes with translational screening. The ready-to-screen format supports reproducible viability, sequencing, and high-content workflows while reducing compound-preparation bottlenecks.
-
Olsalazine Sodium: From Inflammation to Translation
2026-09-14
A translational framework for using Olsalazine Sodium to connect LTB4-driven inflammatory biology, colorectal cancer tumor models, and emerging xenobiotic transport research while preserving experimental rigor.
-
Carvedilol: β-Adrenergic Research Guide
2026-09-13
Carvedilol is a nonselective β-adrenergic receptor antagonist with α1-adrenergic antagonism, antioxidant activity, and vascular-growth effects. Evidence supports its use in receptor signaling, oxidative stress inhibition, vascular smooth muscle cell assays, and carefully controlled hematopoietic-transplant research.
-
AL-8810 for Reliable FP-Receptor Assays
2026-09-12
This scenario-based guide explains how AL-8810 (SKU B4575) can improve interpretation of FP-receptor experiments involving viability, signaling, smooth muscle, and endometrial models. It combines product data, practical handling guidance, and literature context to support reproducible study of prostaglandin F2α signaling.
-
Ceftolozane Sulfate: Assay and PK/PD Workflows
2026-09-12
Ceftolozane sulfate supports resistance-aware susceptibility testing, mechanistic PBP studies, and translational PK/PD modeling focused on Pseudomonas aeruginosa. This guide connects a practical broth microdilution workflow with neutropenic mouse thigh infection model design, comparator selection, and troubleshooting for reproducible results.
-
CAPE Inhibits TcdB and Modulates C. difficile Infection
2026-09-11
Guo and colleagues identify caffeic acid phenethyl ester (CAPE) as a small-molecule inhibitor of the Clostridioides difficile toxin TcdB and show activity in a murine infection model. The study links toxin neutralization with changes in gut microbiota and metabolites, positioning CAPE as a lead for antivirulence and anti-infection research while highlighting the need for stronger binding and translational evidence.
-
EdU Imaging Kits (Cy5) for HBV-HCC Studies
2026-09-11
Translate HBV-HCC signaling hypotheses into quantitative S-phase data with a far-red EdU workflow optimized for microscopy and flow cytometry. This guide connects the quercetin–EGFR study to practical proliferation, genotoxicity, and pharmacodynamic assay design while preserving morphology and antigen accessibility.